- Home
- NXL vs AMPG Comparison
NXL vs AMPG Comparison
Compare NXL & AMPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NXL
- AMPG
- Stock Information
- Founded
- NXL 2010
- AMPG 2002
- Country
- NXL United States
- AMPG United States
- Employees
- NXL N/A
- AMPG N/A
- Industry
- NXL Medical Specialities
- AMPG Telecommunications Equipment
- Sector
- NXL Health Care
- AMPG Telecommunications
- Exchange
- NXL Nasdaq
- AMPG Nasdaq
- Market Cap
- NXL 31.1M
- AMPG 29.1M
- IPO Year
- NXL 2022
- AMPG N/A
- Fundamental
- Price
- NXL $1.69
- AMPG $1.54
- Analyst Decision
- NXL Strong Buy
- AMPG Strong Buy
- Analyst Count
- NXL 1
- AMPG 1
- Target Price
- NXL $5.00
- AMPG $5.00
- AVG Volume (30 Days)
- NXL 117.5K
- AMPG 349.3K
- Earning Date
- NXL 05-09-2025
- AMPG 05-27-2025
- Dividend Yield
- NXL N/A
- AMPG N/A
- EPS Growth
- NXL N/A
- AMPG N/A
- EPS
- NXL N/A
- AMPG N/A
- Revenue
- NXL $168,721.00
- AMPG $9,508,372.00
- Revenue This Year
- NXL $79.59
- AMPG $82.37
- Revenue Next Year
- NXL $334.65
- AMPG $76.47
- P/E Ratio
- NXL N/A
- AMPG N/A
- Revenue Growth
- NXL 52.35
- AMPG N/A
- 52 Week Low
- NXL $0.53
- AMPG $0.64
- 52 Week High
- NXL $4.49
- AMPG $6.43
- Technical
- Relative Strength Index (RSI)
- NXL 37.97
- AMPG 50.67
- Support Level
- NXL $1.56
- AMPG $1.30
- Resistance Level
- NXL $2.31
- AMPG $1.75
- Average True Range (ATR)
- NXL 0.23
- AMPG 0.15
- MACD
- NXL 0.01
- AMPG 0.03
- Stochastic Oscillator
- NXL 24.27
- AMPG 61.11
About NXL Nexalin Technology Inc.
Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.
About AMPG Amplitech Group Inc.
AmpliTech Group Inc designs, develops, engineers, and assembles micro-wave component-based amplifiers that meet individual customer specifications. The products of the company consist of RF amplifiers & related subsystems, operating at multiple frequencies from 50kHz to 44GHz, including Low Noise Amplifiers, Medium Power Amplifiers, cryogenic amplifiers, and custom assemblies. The company also offers non-recurring engineering services on a project-by-project basis, for a predetermined fixed contractual amount, or on a time-plus-material basis. It also operates as a manufacturer, & distributor of cryogenic microwave amplifiers, RF designs, & applications for Wireless Networks & the future of Wireless Communication.